A federal study found Gilead's remdesivir cut recovery time in some COVID-19 patients.
Study finds increased weight gains with newer antiretroviral drugs.
The decision was announced just days before the Conference on Retroviruses and Opportunistic Infections was to take place.
A generic form of the HIV prevention drug from Teva Pharmaceuticals will come earlier than anticipated — but activists are calling for greater access.
An antibiotic commonly prescribed to treat an HIV-related illness might cause coronary problems years later.
Shigella can be especially serious in HIV-positive people with a low CD4 count.
The infections are traumatic, deadly, and avoidable.